Ibrahim Y. A.
- Country
- France
- Department
- Hématologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 17 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating advanced blood cancers, with particular focus on multiple myeloma and various forms of lymphoma. Their expertise extends to managing both relapsed and refractory cases.
- Multiple Myeloma Management
- Diffuse Large B-cell Lymphoma
- Indolent Non-Hodgkin Lymphoma
- High-risk Myeloid Malignancies
Their work includes novel approaches in treating aggressive and treatment-resistant blood cancers.
Cell Therapy Innovation
The investigator has significant involvement in CAR-T cell therapy development and implementation, including both BCMA-directed and CD19-targeted approaches.
- Durcabtagene Autoleucel
- Ciltacabtagene Autoleucel
- Axicabtagene Ciloleucel
- NEX-T CAR T Cells
Their research encompasses both hematologic malignancies and autoimmune conditions.
Transplantation Medicine
The investigator focuses on stem cell transplantation procedures and managing associated complications, particularly Graft versus Host Disease.
- Allogeneic Stem Cell Transplantation
- Steroid-Refractory GvHD
- Mesenchymal Stromal Cell Therapy
- Conditioning Regimens
Their expertise includes novel therapeutic approaches for transplant-related complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.